Prevalence and associated factors of fatigue among breast cancer patients in Malaysia—A prospective study

Fares M. S. Muthanna Muhammad Shahid Iqbal Mahmathi Karuppannan Egbal Abdulrahman Najmee Adulyarat Mokhtar AbdHafiz AbdAlhamid Al-Ghorafi Humam Shaaban Barhoum   

Open Access   

Published:  Jun 16, 2022


The aim of this study was to determine the prevalence and factors associated with fatigue among breast cancer patients in Malaysia. This study was a prospective observational study and data were collected from medical records of Hospital Kuala Lumpur, University of Malaya Medical Center, and National Cancer Institute in the period between July 2019 and April 2020. The incidence of fatigue was determined by detecting whether or not fatigue developed during the course of chemotherapy. Severity of fatigue was determined by the Brief Fatigue Inventory scale after informed written consent was obtained. A chi-squared test was used to analyze the correlations between categorical variables, and logistic regression was used to evaluate the associations of risk factors with the presence of cancerrelated fatigue. Out of a total population of 576 breast cancer patients, 292 had met the inclusion criteria and fatigue occurred at a rate of 58.9%. Our findings indicated that age, body mass index, smoking, number of chemotherapy regimens, fluorouracil, epirubicin, and cyclophosphamide were all associated with the presence of fatigue among breast patients (p < 0.05). This study finds that the prevalence of fatigue in breast cancer patients was high and suggests that effective management of both demographic and clinical factors may reduce fatigue severity and improve the overall health status of cancer patients.

Keyword:     Cancer-related fatigue prevalence associated factors breast cancer.


Muthanna FMS, Iqbal MS, Karuppannan M, Abdulrahman E, Adulyarat N, Al-Ghorafi MAA, Barhoum HS. Prevalence and associated factors of fatigue among breast cancer patients in Malaysia-A prospective study. J Appl Pharm Sci, 2022. Onlilne First.

Copyright: © The Author(s). This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

HTML Full Text


Abrahams HJ, Gielissen MF, Schmits IC, Verhagen CA, Rovers MM, Knoop H. Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors. Ann Oncol, 2016; 27(6):965-74.

Al Maqbali M, Al Sinani M, Al Naamani Z, Al Badi K, Tanash MI. Prevalence of fatigue in patients with cancer: a systematic review and meta-analysis. J Pain Symptom Manage, 2020; 61(1):167-89.e14.

Banipal RPS, Singh H, Singh B. Assessment of cancer-related fatigue among cancer patients receiving various therapies: a cross-sectional observational study. Indian J Palliat Care, 2017; 23(2):207.

Berger AM, Abernethy AP, Atkinson A, Barsevick AM, Breitbart WS, Cella D, Cimprich B, Cleeland C, Eisenberger MA, Escalante CP, Jacobsen PB, Kaldor P, Ligibel JA, Murphy BA, O'Connor T, Pirl WF, Rodler E, Rugo HS, Thomas J, Wagner LI. NCCN Clinical Practice Guidelines cancer-related fatigue. J Natl Compr Canc Netw, 2010; (8):904-31.

Bower JE. Cancer-related fatigue-mechanisms, risk factors, and treatments. Nat Rev Clin Oncol, 2014; 11(10):597-609.

Catania G, Bell C, Ottonelli S, Marchetti M, Bryce J, Grossi A. Cancer-related fatigue in Italian cancer patients: validation of the Italian version of the Brief Fatigue Inventory (BFI). Support Care Cancer, 2013; 21(2):413-9.

Dawson D, Ian Noy Y, Härmä M, Akerstedt T, Belenky G. Modelling fatigue and the use of fatigue models in work settings. Accid Anal Prev, 2011; 43(2):549-64.

Denduluri N, Lyman GH, Wang Y, Morrow PK, Barron R, Patt D, Bhowmik D, Li X, Bhor M, Fox P, Dhanda R, Saravanan S, Jiao X, Garcia J, Crawford J. Chemotherapy dose intensity and overall survival among patients with advanced breast or ovarian cancer. Clin Breast Cancer, 2018; 18(5):380-6.

Fabi A, Falcicchio C, Giannarelli D, Maggi G, Cognetti F, Pugliese P. The course of cancer related fatigue up to ten years in early breast cancer patients: what impact in clinical practice? Breast (Edinburgh, Scotland), 2017; (34):44-52.

Family L, Xu L, Xu H, Cannavale K, Sattayapiwat O, Page JH, Bohac C, Chao C. The effect of chemotherapy-induced anaemia on dose reduction and dose delay. Support Care Cancer, 2016; 24(10):4263-71.

Giacalone A, Quitadamo D, Zanet E, Berretta M, Spina M, Tirelli U. Cancer-related fatigue in the elderly. Support Care Cancer, 2013; 21(10):2899-911.

Gullett JM, Cohen RA, Yang GS, Menzies VS, Fieo RA, Kelly DL, Starkweather AR, Jackson-Cook CK, Lyon DE. Relationship of fatigue with cognitive performance in women with early-stage breast cancer over 2 years. Psychooncology, 2019; 28(5):997-1003.

Inglis JE, Janelsins MC, Culakova E, Mustian KM, Lin PJ, Kleckner IR, Peppone LJ. Longitudinal assessment of the impact of higher body mass index on cancer-related fatigue in patients with breast cancer receiving chemotherapy. Support Care Cancer, 2010; 28(3):1411-8.

Karthikeyan G, Jumnani D, Prabhu R, Manoor U, Supe S. Prevalence of fatigue among cancer patients receiving various anticancer therapies and its impact on quality of life: a cross-sectional study. Indian J Palliat Care, 2018; 18(3):165.

Liutkauskiene S, Grizas S, Jureniene K, Suipyte J, Statnickaite A, Juozaityte E. Retrospective analysis of the impact of anthracycline dose reduction and chemotherapy delays on the outcomes of early breast cancer molecular subtypes. BMC Cancer, 2018; 18(1):453.

Mahoney SE, Davis JM, Murphy EA, McClellan JL, Gordon B, Pena MM. Effects of 5-fluorouracil chemotherapy on fatigue: role of MCP1. Brain Behav Immun, 2013; 27(1):155-61.

Mao H, Bao T, Shen X, Li Q. Prevalence and risk factors for fatigue among breast cancer survivors on aromatase inhibitors. Eur J Cancer, 2018; (101):47-54.

McVinnie DS. Obesity and pain. Br J Pain, 2013; 7(4):163-70.

Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, Huber SL. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer, 1999; 85(5):1186-96.<1186::AID-CNCR24>3.0.CO;2-N

Muhamad H, Roodenburg J, Moore DW. The adaptation of the Big Five Inventory in measuring Malaysian youths' personality traits. Int J Adv Appl Sci, 2018; 5(7):8-14.

Muthanna FMS, Karuppannan M, Hassan BAR, Mohammed AH. Impact of fatigue on quality of life among breast cancer patients receiving chemotherapy. Osong Public Health Res Perspect, 2021; 12(2):115.

Muthanna F, Karuppannan M, Abdulrahman E, Uitrakul S, Rasool BAH, Mohammed AH. Prevalence and associated factors of anemia among breast cancer patients undergoing chemotherapy: a prospective study. Adv Pharmacol Pharm Sci, 2022; 2022:7611733.

Peppone LJ, Mustian KM, Morrow GR, Dozier AM, Ossip DJ, Janelsins MC, Sprod LK, McIntosh S. The effect of cigarette smoking on cancer treatment-related side effects. Oncologist, 2011; 16(12):1784-92.

Phillips KM, Pinilla-Ibarz J, Sotomayor E, Lee MR, Jim HS, Small BJ, Sokol L, Lancet J, Tinsley S, Sweet K, Komrokji R, Jacobsen PB. Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison. Support Care Cancer, 2013; 21(4):1097-103.

Prigozin A, Uziely B, Musgrave CF. The relationship between symptom severity and symptom interference, education, age, marital status, and type of chemotherapy treatment in Israeli women with early-stage breast cancer. Oncol Nurs Forum, 2010; 37(6):E411-8.

Reyes-Gibby CC, Wang J, Spitz M, Wu X, Yennurajalingam S, Shete S. Genetic variations in interleukin-8 and interleukin-10 are associated with pain, depressed mood, and fatigue in lung cancer patients. J Pain Symptom Manage, 2013; 46(2):161-72.

Rowe PC, Underhill RA, Friedman KJ, Gurwitt A, Medow MS, Schwartz MS, Speight N, Stewart JM, Vallings R, Rowe KS. Myalgic encephalomyelitis/chronic fatigue syndrome diagnosis and management in young people: a primer. Front Pediatr, 2017; 5:121.

Sathian B, Sreedharan J, Baboo SN, Sharan K, Abhilash E, Rajesh E. Relevance of sample size determination in medical research. Nepal J Epidemiol, 2010;1(1):4-10.

Scott A, Smith TM. Estimation in multi-stage surveys. J Am Stat Assoc, 1969; 64(327):830-40.

Shuman-Paretsky MJ, Belser-Ehrlich J, Holtzer R. Psychometric properties of the Brief Fatigue Inventory in community-dwelling older adults. Arch Phys Med Rehabil, 2014; 95(8):1533-9.

Su WH, Yeh ET, Chen HW, Lai YL, Wu MH. Fatigue among older advanced cancer patients. Int J Gerontol, 2011; 5:84-8.

Sweatt SK, Gower BA, Chieh AY, Liu Y, Li L. Sleep quality is differentially related to adiposity in adults. Psychoneuroendocrinology, 2018; 98:46-51.

Tabrizi FM, Alizadeh S. Cancer related fatigue in breast cancer survivors: in correlation to demographic factors. Maedica, 2017; 12(2):106.

Tian L, Lin L, Li HL, Chen KJ, Zhang XJ, Qian SJ, Hu Y. Prevalence and associated factors of cancer-related fatigue among cancer patients in Eastern China. Oncologist, 2016; 21(11):1349-54.

Weinert D. Age-dependent changes of the circadian system. Chronobiol Int, 2000; 17(3):261-83.

Article Metrics

1 Absract views 0 PDF Downloads 1 Total views

   Abstract      Pdf Download

Related Search

By author names

Citiaion Alert By Google Scholar

Name Required
Email Required Invalid Email Address

Comment required